gamma-aminobutyric acid has been researched along with Cancer-Associated Pain in 6 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The inclusion criteria are adult patients with cancer suffering from neuropathic cancer pain refractory to opioids and gabapentinoids, patients with a Numerical Rating Scale (NRS) pain score of 4 or higher and patients with a total Hospital Anxiety and Depression Scale score of less than 20." | 9.24 | Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study. ( Ariyoshi, K; Ishiki, H; Iwase, S; Kawaguchi, T; Kizawa, Y; Koyama, A; Matsuda, Y; Matsuoka, H; Miyaji, T; Morita, T; Yamaguchi, T, 2017) |
| "Gabapentin has been used as an adjuvant for treatment of cancer pain." | 9.22 | The research on long-term clinical effects and patients' satisfaction of gabapentin combined with oxycontin in treatment of severe cancer pain. ( Chen, DL; Li, YH; Wang, ZJ; Zhu, YK, 2016) |
| "Management of patients with cancer suffering from neuropathic pain refractory to opioids and gabapentinoids remains an important challenge." | 6.84 | Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study. ( Ariyoshi, K; Ishiki, H; Iwase, S; Kawaguchi, T; Kizawa, Y; Koyama, A; Matsuda, Y; Matsuoka, H; Miyaji, T; Morita, T; Yamaguchi, T, 2017) |
| "Gabapentin has been used as an adjuvant for treatment of cancer pain." | 6.82 | The research on long-term clinical effects and patients' satisfaction of gabapentin combined with oxycontin in treatment of severe cancer pain. ( Chen, DL; Li, YH; Wang, ZJ; Zhu, YK, 2016) |
| " Previous studies showed that opioids combined with gabapentin for management of cancer pain reduced the dosage of opioids." | 6.82 | The research on long-term clinical effects and patients' satisfaction of gabapentin combined with oxycontin in treatment of severe cancer pain. ( Chen, DL; Li, YH; Wang, ZJ; Zhu, YK, 2016) |
| " The inclusion criteria are adult patients with cancer suffering from neuropathic cancer pain refractory to opioids and gabapentinoids, patients with a Numerical Rating Scale (NRS) pain score of 4 or higher and patients with a total Hospital Anxiety and Depression Scale score of less than 20." | 5.24 | Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study. ( Ariyoshi, K; Ishiki, H; Iwase, S; Kawaguchi, T; Kizawa, Y; Koyama, A; Matsuda, Y; Matsuoka, H; Miyaji, T; Morita, T; Yamaguchi, T, 2017) |
| "Gabapentin has been used as an adjuvant for treatment of cancer pain." | 5.22 | The research on long-term clinical effects and patients' satisfaction of gabapentin combined with oxycontin in treatment of severe cancer pain. ( Chen, DL; Li, YH; Wang, ZJ; Zhu, YK, 2016) |
| "Management of patients with cancer suffering from neuropathic pain refractory to opioids and gabapentinoids remains an important challenge." | 2.84 | Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study. ( Ariyoshi, K; Ishiki, H; Iwase, S; Kawaguchi, T; Kizawa, Y; Koyama, A; Matsuda, Y; Matsuoka, H; Miyaji, T; Morita, T; Yamaguchi, T, 2017) |
| "Gabapentin has been used as an adjuvant for treatment of cancer pain." | 2.82 | The research on long-term clinical effects and patients' satisfaction of gabapentin combined with oxycontin in treatment of severe cancer pain. ( Chen, DL; Li, YH; Wang, ZJ; Zhu, YK, 2016) |
| " Previous studies showed that opioids combined with gabapentin for management of cancer pain reduced the dosage of opioids." | 2.82 | The research on long-term clinical effects and patients' satisfaction of gabapentin combined with oxycontin in treatment of severe cancer pain. ( Chen, DL; Li, YH; Wang, ZJ; Zhu, YK, 2016) |
| "Compared with nociceptive pain, neuropathic pain is a challenging diagnosis to make and successfully treat in children with cancer." | 1.46 | Very-Low-Dose Methadone To Treat Refractory Neuropathic Pain in Children with Cancer. ( Bruera, E; Madden, K, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Yeo, M | 1 |
| Chen, Y | 1 |
| Jiang, C | 1 |
| Chen, G | 1 |
| Wang, K | 1 |
| Chandra, S | 1 |
| Bortsov, A | 1 |
| Lioudyno, M | 1 |
| Zeng, Q | 1 |
| Wang, P | 1 |
| Wang, Z | 1 |
| Busciglio, J | 1 |
| Ji, RR | 1 |
| Liedtke, W | 1 |
| Corona-Ramos, JN | 1 |
| Déciga-Campos, M | 1 |
| Romero-Piña, M | 1 |
| Medina, LA | 1 |
| Martínez-Racine, I | 1 |
| Jaramillo-Morales, OA | 1 |
| García-López, P | 1 |
| López-Muñoz, FJ | 1 |
| Madden, K | 1 |
| Bruera, E | 1 |
| Matsuoka, H | 1 |
| Ishiki, H | 1 |
| Iwase, S | 1 |
| Koyama, A | 1 |
| Kawaguchi, T | 1 |
| Kizawa, Y | 1 |
| Morita, T | 1 |
| Matsuda, Y | 1 |
| Miyaji, T | 1 |
| Ariyoshi, K | 1 |
| Yamaguchi, T | 1 |
| Ge, MM | 1 |
| Chen, SP | 1 |
| Zhou, YQ | 1 |
| Li, Z | 1 |
| Tian, XB | 1 |
| Gao, F | 1 |
| Manyande, A | 1 |
| Tian, YK | 1 |
| Yang, H | 1 |
| Chen, DL | 1 |
| Li, YH | 1 |
| Wang, ZJ | 1 |
| Zhu, YK | 1 |
2 trials available for gamma-aminobutyric acid and Cancer-Associated Pain
| Article | Year |
|---|---|
Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study.
Topics: Adult; Aged; Amines; Analgesics; Analgesics, Opioid; Cancer Pain; Cyclohexanecarboxylic Acids; Doubl | 2017 |
The research on long-term clinical effects and patients' satisfaction of gabapentin combined with oxycontin in treatment of severe cancer pain.
Topics: Adult; Amines; Analgesics; Cancer Pain; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Dru | 2016 |
4 other studies available for gamma-aminobutyric acid and Cancer-Associated Pain
| Article | Year |
|---|---|
Repurposing cancer drugs identifies kenpaullone which ameliorates pathologic pain in preclinical models via normalization of inhibitory neurotransmission.
Topics: Action Potentials; Analgesics; Animals; Benzazepines; Cancer Pain; Catenins; Cells, Cultured; Delta | 2021 |
The Effect of Gabapentin and Tramadol in Cancer Pain Induced by Glioma Cell in Rat Femur.
Topics: Amines; Analgesics; Animals; Bone Neoplasms; Brain Neoplasms; Cancer Pain; Cell Line, Tumor; Cell Su | 2017 |
Very-Low-Dose Methadone To Treat Refractory Neuropathic Pain in Children with Cancer.
Topics: Amines; Analgesics; Analgesics, Opioid; Cancer Pain; Child; Child, Preschool; Chronic Pain; Cyclohex | 2017 |
The therapeutic potential of GABA in neuron-glia interactions of cancer-induced bone pain.
Topics: Animals; Bone Neoplasms; Cancer Pain; Cell Communication; Cell Line, Tumor; Female; GABA Plasma Memb | 2019 |